Alpha 2.0
Login Register
» Authors » Jan L N Roodenburg

Jan L N Roodenburg

Explore the profile of Jan L N Roodenburg including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 1398
Followers 0
Related Specialties
Oncology
General Surgery
Dentistry
Top 10 Co-Authors
Bernard F A M van der Laan
Pieter U Dijkstra
Arjan Vissink
Max J H Witjes
Johannes A Langendijk
Harriet Jager-Wittenaar
Harry Reintsema
Gyorgy B Halmos
Jan Pruim
Gerry M Raghoebar
Published In
Head Neck
Support Care Cancer
Oral Oncol
Radiother Oncol
Lasers Surg Med
Affiliations
Soon will be listed here.
Recent Articles
1.
Malnutrition risk and frailty in head and neck cancer patients: coexistent but distinct conditions
Dewansingh P, Bras L, Ter Beek L, Krijnen W, Roodenburg J, van der Schans C, et al.
Eur Arch Otorhinolaryngol . 2022 Dec; 280(4):1893-1902. PMID: 36484854
Purpose: Both malnutrition and frailty are associated with adverse treatment outcomes. Malnutrition (risk) and frailty are each commonly present in patients with head and neck cancer (HNC). However, their coexistence...
2.
Perception and Performance of Physical Activity Behavior after Head and Neck Cancer Treatment: Exploration and Integration of Qualitative and Quantitative Findings
Sealy M, Stuiver M, Midtgaard J, van der Schans C, Roodenburg J, Jager-Wittenaar H
Int J Environ Res Public Health . 2022 Jan; 19(1). PMID: 35010547
Maintaining or increasing physical activity (PA) may prevent loss of muscle mass and strength after completion of head and neck cancer (HNC) treatment. However, the exercise level of HNC patients...
3.
Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm
Boeve K, Mastik M, Slagter-Menkema L, van Dijk B, Roodenburg J, van der Laan B, et al.
Head Neck . 2021 May; 43(9):2688-2697. PMID: 34008248
Background: In this feasibility study we aimed to evaluate the value of previously reported molecular tumor biomarkers associated with lymph node metastasis in oral squamous cell carcinoma (OSCC) to optimize...
4.
Reorganizing the Multidisciplinary Team Meetings in a Tertiary Centre for Gastro-Intestinal Oncology Adds Value to the Internal and Regional Care Pathways. A Mixed Method Evaluation
van Huizen L, Dijkstra P, Hemmer P, van Etten B, Buis C, Olsder L, et al.
Int J Integr Care . 2021 Mar; 21(1):8. PMID: 33664641
Introduction: The reorganisation of the structure of a Gastro-Intestinal Oncology Multidisciplinary Team Meeting (GIO-MDTM) in a tertiary centre with three care pathways is evaluated on added value. Methods: In a...
5.
Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review
van der Geer S, van Rijn P, Roodenburg J, Dijkstra P
Head Neck . 2020 Jun; 42(9):2696-2721. PMID: 32558025
Background: To prescribe early trismus therapy, prognostic factors influencing the restricted mouth opening should be identified first. Our aim is to present an overview of these factors in patients with...
6.
Targeted Photodynamic Therapy of Human Head and Neck Squamous Cell Carcinoma with Anti-epidermal Growth Factor Receptor Antibody Cetuximab and Photosensitizer IR700DX in the Mouse Skin-fold Window Chamber Model
Peng W, de Bruijn H, Ten Hagen T, van Dam G, Roodenburg J, Berg K, et al.
Photochem Photobiol . 2020 Mar; 96(3):708-717. PMID: 32222965
Targeted photodynamic therapy (PDT) in head/neck cancer patients with a conjugate of the anti-epidermal growth factor receptor (EGFR) antibody, Cetuximab and a phthalocyanine photosensitizer IR700DX is under way, but the...
7.
In-Vivo Optical Monitoring of the Efficacy of Epidermal Growth Factor Receptor Targeted Photodynamic Therapy: The Effect of Fluence Rate
Peng W, de Bruijn H, Ten Hagen T, Berg K, Roodenburg J, van Dam G, et al.
Cancers (Basel) . 2020 Jan; 12(1). PMID: 31940973
Targeted photodynamic therapy (PDT) has the potential to improve the therapeutic effect of PDT due to significantly better tumor responses and less normal tissue damage. Here we investigated if the...
8.
The use of stretching devices for treatment of trismus in head and neck cancer patients: a randomized controlled trial
van der Geer S, Reintsema H, Kamstra J, Roodenburg J, Dijkstra P
Support Care Cancer . 2019 Nov; 28(1):9-11. PMID: 31701267
Purpose: To compare the effects of two stretching devices, the TheraBite® Jaw Motion Rehabilitation System™ and the Dynasplint Trismus System®, on maximal mouth opening in head and neck cancer patients....
9.
Self-Completion of the Patient-Generated Subjective Global Assessment Short Form Is Feasible and Is Associated With Increased Awareness on Malnutrition Risk in Patients With Head and Neck Cancer
Jager-Wittenaar H, de Bats H, Welink-Lamberts B, Gort-van Dijk D, van der Laan B, Ottery F, et al.
Nutr Clin Pract . 2019 May; 35(2):353-362. PMID: 31134665
Background: We aimed to assess feasibility of self-completion of the Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) by head and neck cancer patients, and to assess self-reported increased awareness...
10.
Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer
Sealy M, Dechaphunkul T, van der Schans C, Krijnen W, Roodenburg J, Walker J, et al.
Clin Nutr . 2019 Mar; 39(2):501-509. PMID: 30846324
Background & Aims: We studied whether low pre-treatment muscle mass, measured with CT at thoracic (T4) or lumbar level (L3) associates with early termination of chemotherapy related to toxicity in...